Research Publications

The off- versus on-label use of medical devices in interventional cardiovascular medicine: clarifying the ambiguity between regulatory labeling and clinical decision-making, Part 1: PCI.

Price MJ, Teirstein PS

Dynamics of platelet functional recovery following a clopidogrel loading dose in healthy volunteers.

Price MJ, Teirstein PS

Antiplatelet therapy in acute coronary syndromes.

Barker CM, Price MJ

New antiplatelet therapies in development.

Price MJ

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.

Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP, Ernst A, Sawhney NS, Schatz RA, Teirstein PS

A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease.

Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni P, Valgimigli M, Migliorini A, Antoniucci D, Carrié D, Sangiorgi G, Chieffo A, Colombo A, Price MJ, Teirstein PS, Christiansen EH, Abbate A, Testa L, Gunn JP, Burzotta F, Laudito A, Trevi GP, Sheiban I

Clopidogrel desensitization after drug-eluting stent placement.

von Tiehl KF, Price MJ, Valencia R, Ludington KJ, Teirstein PS, Simon RA

Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial).

Valencia R, Price MJ, Sawhney N, Lee SS, Wong GB, Gollapudi RR, Banares M, Schatz RA, Teirstein PS

The effect of granulocyte colony stimulating factor on regional and global myocardial function in the porcine infarct model.

Lee SS, Naqvi TZ, Forrester J, Cattley R, Shah A, Frantzen M, Miyamoto T, Kaufman S, Price MJ, Lill M, Makkar RR

Utility of three-dimensional reconstruction of coronary angiography to guide percutaneous coronary intervention.

Gollapudi RR, Valencia R, Lee SS, Wong GB, Teirstein PS, Price MJ